Bayer AG News

MADE IN TAIWAN: The company that made the pig vaccine plans to apply for permits to sell it in other countries now that it has been given the all-clear STAFF WRITER, WITH CNA Friday, Jul 11, 2008, Page 4 A ...

Climate protection projects rigorously implemented / Commitment to global health care provision / EUR 45 million spent annually to support 300 social projects worldwide / EUR 500,000 per year alone to support ...

Energy-efficient process recycles chlorine from hydrochloric acid / Industrial application in Germany and China / Bayer Management Board member Dr.

FRANKFURT, Germany : German chemical and pharmaceutical company Bayer AG said Tuesday it had signed a supply and licensing agreement with American generic drug manufacturer Barr Pharmaceuticals Inc.

FRANKFURT, Germany : German pharmaceutical and chemical company Bayer AG said Monday it would invest 100 million in its Brazilian operations through the end of 2009.

Swiss vaccine developer AmVac AG is teaming up with Bayer AG subsidiary Icon Genetics GmbH to develop a plant-based production system for making an adjuvanted influenza vaccine.

Medicinal products from plants or even tobacco for health could soon become reality.

A young Australian filmmaker and an Indian child combating water waste are among the 700 children from over 100 countries that are sharing their stories on how to create a better, healthier planet at a United ...

“A merger between Bayer and SPC is desirable and advantageous for both corporations and their respective stockholders because it will make possible the more productive use of the properties and resources of the constituent corporations”

Bayer Philippines, Inc., the local unit of German firm Bayer AG, will absorb with Schering Philippine Corporation , a subsidiary of the company, in a merger. via Manila Bulletin

Human rights activists "ethically and morally" condemned 24 European corporations on Friday, accusing them of environmental contamination, labor exploitation and selling dangerous pesticides in Latin America. via Fort Worth Star-Telegram

Bayer AG plans to recall the remaining supplies of its drug Trasylol for blood clotting from the U.S. market according to the Food and Drug Administration. via International Business Times

“In all likelihood, this is the end of the aprotinin story”

Bayer AG, the maker of the drug Trasylol, said it is still deciding what to do and is awaiting details from the Canadian study. via Kpic.com

“The fear of a financial meltdown has gone away.”

The Dow Jones Stoxx 600 Index added 2.3% to 329.21 this past week, the highest since February 27. via Gulf Times

European stocks rose for a second week, led by technology companies and drugmakers, after Ericsson AB and Bayer AG reported better-than-estimated earnings and UCB SA won U.S. approval for a new Crohn's disease ... via Bloomberg.com

Pepsi Chugs Along on Foreign Sales; Credit Suisse Continues its Struggles; Peltz is Thinkin' Wendy's; Drugmakers' Earnings Sedated; Dubai Aerospace to Dump $2 Billion on More Planes; Merrill Maintains Dividend; ... via Money Morning

“We carried over the previous year's positive trend in both sales and earnings, and this strengthens our confidence for the year as a whole”

The Bayer Group posted excellent results in the first quarter of 2008. "We carried over the previous year's positive trend in both sales and earnings, and this strengthens our confidence for the year as a ... via Rubber World

“We are not aware of any lawsuit outside the United States”

Germany's Bayer AG is facing 78 lawsuits in the United States linked to its Trasylol drug used to stem bleeding during open heart surgery, its chief executive said on Friday. via Reuters

Bayer AG, whose products include medicines and pesticides, said Thursday that its first-quarter net profit slid nearly 73 percent from figures last year that were boosted by one-time gains. via International Business Times

The lawsuits involving the drug Trasylol were filed in federal court in West Palm Beach by St. via WCTV Tallahassee

A team of researchers from the Japan unit of German chemical giant Bayer A.G. was successful last year in producing induced pluripotent stem cells, or iPS cells, from human skin cells, that would behave like ... via Kyodo News